Prostate cancer is the most common cancer among men, and it's the second leading cause of cancer death for men in the U.S.

The UK media is overstating the benefits of prostate specific antigen tests, which can result in risk without benefit, says ...

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests. Results of the long-term European trial – one of the largest in ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

African American men in Cuyahoga County have a 60% increased risk of being diagnosed with prostate cancer and an 80% increased risk of dying from prostate cancer compared to white men, according to ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) sheds new light on the long-term impact of ...

A major trial has found that prostate cancer screening for all men over 50 would save thousands of lives in Britain. The study involved data from 162,000 men aged between 55 to 69 from eight European ...

As part of an EU-wide initiative to screen for prostate cancer, researchers in Ireland are studying whether a simple home finger-prick PSA blood test can help detect the disease earlier and save more ...